High-dose mitomycin-C with autologous bone marrow transplantation in patients with refractory malignancies. Influence of dose schedule on pharmacokinetics and nonhematopoietic toxicities.

Source:http://linkedlifedata.com/resource/pubmed/id/3096129

Download in:

View as

General Info

PMID
3096129